메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

KCM Trade Unveils Research Report Series

[ 메디채널 황정호 기자 ] Empowering Global Investors with Expert Market Intelligence HONG KONG, Jan. 14, 2026 -- KCM Trade, a global leading Contract for Difference (CFD) broker, today announced the launch of its proprietary research report series with the publication of its inaugural report, "An Annual Review of Global Financial Markets 2025". The initiative represents a strategic expansion of the firm's offering, expanding beyond trade execution to deliver structured, forward-looking market analysis to clients and the wider global investment community. A New Chapter in Clie
- 황정호 기자
- 2026-01-14 12:25
CapitaLand India Data Centre Fund、3拠点のデータセンターに対して20.2％の持分を9,973万シンガポールドルで取得

開発重視型のデータセンターファンドは、ファーストクローズ時に約1億5,000万シンガポールドルの資本を調達しましたシンガポール、2026年1月14日 -- 世界有数の不動産資産運用会社CapitaLand Investment Limited (CLI)は、CapitaLand India Data Centre Fund (CIDCF)の第1次募集で約1億5,000万シンガポールドルの資金調達に成功しました。CIDCFは、インドの主要データセンター回廊におけるデータセンター開発の機会に注力しています。 CIDCFは、第三者のグローバル機関投資家を基軸として約1億5,000万シンガポールドルのファーストクローズを実施し、CLIからもGP出資が行われました。同ファンドは、最終クローズで約3億シンガポールドルの調達を目指しています。第一回目の買収完了により、CIDCFはCapitaLand India Trust（CLINT）から3つのデータセンターそれぞれの20.2%の権益を取得し、その総買収額は推定9,973万シンガポールドル（70.2億インドルピー）となる[1]。さらに、CIDCF は、バンガロールにある CLINT の 4 番目のデータセンターである CapitaLand DC Ban
- 황정호 기자
- 2026-01-14 12:11
Angela Zhao Named CEO of GLP China

GLP appoints its China head of logistics and industrial real estate to lead integrated business spanning logistics, digital infrastructure and new energy, and fund management The newly created China CEO role will report to Ming Mei, who continues as Global CEO Teresa Zhuge, immediate past Executive Vice Chairwoman of GLP China, moves into expanded global leadership role while remaining on GLP China Board of Directors SINGAPORE, Jan. 14, 2026 -- GLP Pte Ltd ("GLP" and with its subsidiaries the "Group") today announced the appointment of Angela Zhao a
- 황정호 기자
- 2026-01-14 12:00
Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer

HONG KONG, Jan. 14, 2026 -- Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI), comparing cadonilimab plus chemotherapy against a PD-1 inhibitor plus chemotherapy for the first-line (1L) treatment for advanced gastric (G) or gastroesophageal junction (GEJ) cancer with PD-L1 CPS <5 (a propensity-matched, retrospective cohort study). The study results showed that the cadonilimab regimen, compared to the PD-1 monoclonal antibody regimen, significantly prolonged patients' o
- 김갑성 기자
- 2026-01-14 11:54
Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting

MELBOURNE, Australia, Jan. 14, 2026 -- Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated geneTypeTM Colorectal Cancer (CRC) Risk Assessment clinical test ("geneTypeTM CRC"), a significant advancement in personalised cancer risk prediction. The updated test incorporates additional clinical and lifestyle risk factors alongside the established 140-SNP polygenic risk score (PRS), delivering improved predictive accuracy across both
- 김갑성 기자
- 2026-01-14 11:40
Avestar Capital Launches Singapore Office

US-Based Multi-Family Office Strengthens Global Footprint to Serve Asia's Ultra-Wealthy Families SINGAPORE, Jan. 14, 2026 -- Avestar Capital, a leading U.S.-based multi-family office, today announced the official launch of its Singapore operations under AVESTAR SINGAPORE PLC PTE. LTD., marking a major milestone in its global expansion strategy. The new office will serve as Avestar's Asia-Pacific hub, extending its founder-led approach to tailored wealth management for ultra-high-net-worth (UHNW) families across the region. Founded and led by Xerxes Mullan, Avestar Capita
- 황정호 기자
- 2026-01-14 10:31
AWOL Vision Announces NFL Quarterback Kirk Cousins as Brand Ambassador Following CES 2026 Debut

SHENZHEN, China, Jan. 14, 2026 -- AWOL Vision, a global leader in next-generation audiovisual technology, announced NFL quarterback Kirk Cousins as its Brand Ambassador, representing both AWOL Vision and its premium sub-brand, Valerion. The partnership debuts at CES 2026 alongside the launch of Aetherion series, AWOL Vision's latest ultra-short-throw (UST) projector lineup. Known for his accuracy, preparation, and leadership on the field, Kirk Cousins embodies a relentless pursuit of excellence that mirrors AWOL Vision's commitment to engineering breakthrough, user-focused tech
- 황정호 기자
- 2026-01-14 10:27
HALO LAUNCHES "ARR MILESTONES" -- CUSTOMER PRICING REDUCES AS COMPANY GROWS

[ 메디채널 황정호 기자 ] Privately owned, product-led enterprise software vendor to apply public, company-level ARR thresholds that unlock global license discounts for customers on standard pricing; launches at ∼£100m ARR with a 5% reduction, compounding at every milestone. LONDON, Jan. 14, 2026 -- Halo today announced ARR Milestones, an industry-first pricing programme that turns company growth into direct customer savings. When Halo's company Annual Recurring Revenue (ARR) reaches a published milestone, Halo will apply a global license discount for customers on standard pricing. The
- 황정호 기자
- 2026-01-14 09:30
Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference

Celltrion outlines a blueprint for innovative drug development built on its antibody expertise The company highlights its business strategy to scale U.S. manufacturing and R&D capabilities, strengthening its global supply chain, production and operations INCHEON, South Korea, Jan. 14, 2026 -- Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today presented key strategic priorities and clinical development updates for its innovative drug pipelines including antibody-drug conjugates (ADCs) and multi-specific antibodies (msAbs) at the 44th Annual
- 김갑성 기자
- 2026-01-14 09:18
Rokid、アジアおよび欧州全域での展開を通じてグローバル小売拡大を加速

[ 메디채널 김장윤(JASON KIM) 기자 ] 米ニューヨーク、2026年1月14日 -- ヒューマン・コンピュータ・インタラクションおよび AI 搭載スマートグラス分野のパイオニアである Rokid は、オフライン小売チャネルのグローバル展開を加速することを発表しました。これにより、Rokid Glasses および Rokid AI Glasses Style を、アジアおよび欧州各地のプレミアムなショッピング拠点を通じて、世界中の消費者により身近な存在として提供していきます。今回の拡大は、Rokid にとって世界的に大きな勢いを示した一年および CES 2026 の成功裏の閉幕を受けたものです。その背景には、過去最高を記録したクラウドファンディングの実績、エコシステムの採用拡大、そして日常利用に適した実用的な AI スマートグラスに対する消費者の関心の高まりがあります。グローバル小売展開の拡大小売チャネル戦略の一環として、Rokid は以下の主要商業拠点への進出を果たしました。英国（11月）: 2025年11月、Rokid は英国を代表する高級百貨店の一つであるSelfridgesに進出し、欧州における小売展開の拡大およびプレミアムチャネルでのポジショニングにおいて重要な節目を
- 김장윤(JASON KIM) 기자
- 2026-01-14 09:10

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2026-01-15_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 15일 14시 00분